Disease recurrence, both local and distal, is an ongoing issue contributing to the majority of hormone receptor-positive breast cancer deaths and is observed in many other types of cancers, such as triple-negative breast cancer, lung, and prostate cancer. This evidence concerns the gene NR4A1 and prostate carcinoma.